3 Drugs Stocks Driving The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices traded up today with the Dow Jones Industrial Average ( ^DJI) trading up 25 points (0.1%) at 17,157 as of Wednesday, Sept. 17, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 1,585 issues advancing vs. 1,500 declining with 127 unchanged.

The Drugs industry as a whole closed the day up 0.5% versus the S&P 500, which was up 0.1%. Top gainers within the Drugs industry included XTL Biopharmaceuticals ( XTLB), up 4.9%, ImmuCell ( ICCC), up 1.5%, Oragenics ( OGEN), up 4.0%, Prima Biomed ( PBMD), up 4.0% and EntreMed ( ENMD), up 3.2%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

EntreMed ( ENMD) is one of the companies that pushed the Drugs industry higher today. EntreMed was up $0.05 (3.2%) to $1.60 on light volume. Throughout the day, 13,901 shares of EntreMed exchanged hands as compared to its average daily volume of 20,800 shares. The stock ranged in a price between $1.52-$1.60 after having opened the day at $1.53 as compared to the previous trading day's close of $1.55.

EntreMed has a market cap of $47.1 million and is part of the health care sector. Shares are up 11.9% year-to-date as of the close of trading on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Higher

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Advancing The Drugs Industry

3 Drugs Stocks Pushing The Industry Higher